Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users

Epidemiology and Infection

Volumn 135, Issue 1, 2007, Pages 144-150

  Amin, J ^a,c   Law, M G ^a   Micallef, J ^a   Jauncey, M ^b   Van Beek, I ^c   Kaldor, J M ^a   Dore, G J ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b New South Wales Government   (Australia)

^c Kirketon Road Centre ^*  (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; COHORT ANALYSIS; DISEASE COURSE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; NONHUMAN; RETROSPECTIVE STUDY; SEROCONVERSION; STANDARDIZATION; VIRUS LOAD; VIRUS SHEDDING;

BIAS (EPIDEMIOLOGY); COHORT STUDIES; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; KAPLAN-MEIERS ESTIMATE; RNA, VIRAL; SUBSTANCE ABUSE, INTRAVENOUS; TIME FACTORS;

EID: 33751376908     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268806006388     Document Type: Article

References (19)

1. Seeff LB. Natural history of chronic hepatitis C. Hepatology 2002; 36: S35-S46.
2. Micallef JK, Kaldor JM, Dore GJ. Estimation of progression to chronic hepatitis C: A systematic review of longitudinal studies. In: 15th Annual Conference of the Australasian Society for HIV Medicine, 2003. Cairns, Australia, 2003.
3. Eyster ME, Sanders J, Goedert JJ. Viral clearance occurs very early during the natural resolution of hepatitis C virus infection in persons with haemophila. Haemophilia 2004; 10: 75-80.
4. Farci P, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. New England Journal of Medicine 1991; 325: 98-104.
5. Alter MJ, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. Journal of the American Medical Association 1990; 264: 2231-2235.
6. Larghi A, et al. Outcome of an outbreak of acute hepatitis C among healthy volunteers participating in pharmacokinetics studies. Hepatology 2002; 36: 993-1000.
7. Villano SA, et al. Persistence of viremia and the importance of long-term follow-up after acute hepatitis C infection. Hepatology 1999; 29: 908-914.
8. Alter MJ, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
9. Law MG, et al. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001. International Journal of Epidemiology 2003; 32: 717-724.
10. Porter K, et al. The practical significance of potential biases in estimates of the AIDS incubation period distribution in the UK register of HIV seroconverters. AIDS 1999; 13: 1943-1951.
11. Jauncey MG, et al. Viral clearance in newly acquired hepatitis C infection among a cohort of injecting drug users. Journal of Infectious Diseases 2004; 190: 1270-1274.
12. Hofer H, et al. Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load. Hepatology 2003; 37: 60-64.
13. Okayama A, et al. Incident hepatitis C virus infection in a community-based population in Japan. Journal of Viral Hepatology 2002; 9: 43-51.
14. Hashimoto M, et al. Fluctuations of hepatitis C virus load are not related to amino acid substitutions in hypervariable region 1 and interferon sensitivity determining region. Journal of Medical Virology 1999; 58: 247-255.
15. Chiarotti F, et al. Effects of different parametric estimates of seroconversion time on analysis of progression to AIDS among Italian HIV-positive haemophiliacs. Statistics in Medicine 1992; 11: 591-601.
16. Schmid P, et al. Analysis of the viability of freezer stored serum samples for hepatitis C virus RNA analysis by the SUPERQUANT method: results of a 16 year retrospective study. Journal of Virological Methods 1999; 82: 201-206.
17. Fattovich G, et al. Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: A cohort study of 297 patients. American Journal of Gastroenterology 2002; 97: 2886-2895.
18. Prati D, et al. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology 1997; 25: 702-704.
19. Jaeckel E, et al. Treatment of acute hepatitis C with interferon alfa-2b. New England Journal of Medicine 2001; 345: 1452-1457.